These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8289873)

  • 1. Toward the design of new inhibitors: a computer modeling approach.
    Faerman CH
    NIDA Res Monogr; 1993; 134():103-13. PubMed ID: 8289873
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficient 3D database screening for novel HIV-1 IN inhibitors.
    Barreca ML; Rao A; De Luca L; Zappalà M; Gurnari C; Monforte P; De Clercq E; Van Maele B; Debyser Z; Witvrouw M; Briggs JM; Chimirri A
    J Chem Inf Comput Sci; 2004; 44(4):1450-5. PubMed ID: 15272853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
    Zhou Z; Bates M; Madura JD
    Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer modelling of G protein-coupled receptors: promises and drawbacks.
    Maigret B
    J Pharm Belg; 1997; 52(2):102. PubMed ID: 9193133
    [No Abstract]   [Full Text] [Related]  

  • 6. Constituting a receptor-ligand information base from quality-enriched data.
    Hemm K; Aberer K; Hendlich M
    Proc Int Conf Intell Syst Mol Biol; 1995; 3():170-8. PubMed ID: 7584434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of phosphofructokinase from Entamoeba histolytica for the prediction of new antiparasitic agents.
    Byington CL; Dunbrack RL; Cohen FE; Agabian N
    Arch Med Res; 1997; 28 Spec No():86-8. PubMed ID: 9033023
    [No Abstract]   [Full Text] [Related]  

  • 9. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development.
    Singh S; Malik BK; Sharma DK
    Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
    Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
    J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling of human transketolase: description of critical sites useful for drug design and study of the cofactor binding mode.
    Obiol-Pardo C; Rubio-Martinez J
    J Mol Graph Model; 2009 Feb; 27(6):723-34. PubMed ID: 19111488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
    Wang JG; Xiao YJ; Li YH; Ma Y; Li ZM
    Bioorg Med Chem; 2007 Jan; 15(1):374-80. PubMed ID: 17049866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial chemistry in the discovery and development of drugs.
    Doyle PM
    J Chem Technol Biotechnol; 1995 Dec; 64(4):317-24. PubMed ID: 8579821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Computer prediction of biological activity spectra for low-molecular peptides and peptidomimetics].
    Martynova NB; Filimonov DA; Poroĭkov VV
    Bioorg Khim; 2000 May; 26(5):330-9. PubMed ID: 10900503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico multi-filter screening approaches for developing novel beta-secretase inhibitors.
    Fujimoto T; Matsushita Y; Gouda H; Yamaotsu N; Hirono S
    Bioorg Med Chem Lett; 2008 May; 18(9):2771-5. PubMed ID: 18434150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABGEN: a knowledge-based automated approach for antibody structure modeling.
    Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
    Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.